Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members

European Urology

Volumn 58, Issue 2, 2010, Pages 275-280

  Brandt, Andreas ^a   Bermejo, Justo Lorenzo ^a,b   Sundquist, Jan ^c,d   Hemminki, Kari ^a,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c LUND UNIVERSITY   (Sweden)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Familial prostate cancer; Familial risk; Population based studies; Prostate cancer; Prostate cancer mortality

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; DATA BASE; DEATH; FAMILIAL CANCER; FAMILY STUDY; FATHER; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; PROSTATE CANCER; RISK; SIBLING; SWEDEN;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 77955309014     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.02.002     Document Type: Article

References (24)

1. H. Gronberg Prostate cancer epidemiology Lancet 361 2003 859 864
2. K. Hemminki, and K. Czene Age specific and attributable risks of familial prostate carcinoma from the family-cancer database Cancer 95 2002 1346 1353
3. M.P. Zeegers, A. Jellema, and H. Ostrer Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis Cancer 97 2003 1894 1903
4. J.S. Witte Prostate cancer genomics: towards a new understanding Nat Rev Genet 10 2009 77 82
5. F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
6. R.A. Smith, V. Cokkinides, and O.W. Brawley Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening CA Cancer J Clin 59 2009 27 41
7. M. Shah, K. Zhu, R.C. Palmer, and H. Wu Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men Prev Med 44 2007 459 464
8. G. Draisma, R. Etzioni, and A. Tsodikov Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context J Natl Cancer Inst 101 2009 374 383
9. H.G. Welch, and P.C. Albertsen Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005 J Natl Cancer Inst 101 2009 1325 1329
10. K. Hemminki, X. Li, K. Plna, C. Granstrom, and P. Vaittinen The nation-wide Swedish family-cancer database - updated structure and familial rates Acta Oncol 40 2001 772 777
11. Centre for Epidemiology. Cancer incidence in Sweden 2006. Stockholm, Sweden: National Board of Health and Welfare, 2007.
12. K. Hemminki, J. Ji, A. Brandt, S.M. Mousavi, and J. Sundquist The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies Int J Cancer 126 2009 2259 2267
13. S.R. Hamilton, L.A. Aaltonen, Pathology and genetics of tumours of the digestive system. World Health Organization Classification of Tumours 2000 International Agency for Research on Cancer Lyon, France
14. T.M. Therneau, and P.M. Grambsch Modeling survival data: extending the Cox model 2000 Springer New York, NY
15. M. Leu, M. Reilly, and K. Czene Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers J Natl Cancer Inst 100 2008 1318 1325
16. K. Hemminki, A. Forsti, and J. Lorenzo Bermejo New cancer susceptibility loci: population and familial risks Int J Cancer 123 2008 1726 1729
17. K. Hemminki, R. Rawal, and J.L. Bermejo Prostate cancer screening, changing age-specific incidence trends and implications on familial risk Int J Cancer 113 2005 312 315
18. P. Stattin, R. Johansson, and J.E. Damber Non-systematic screening for prostate cancer in Sweden - survey from the National Prostate Cancer Registry Scand J Urol Nephrol 37 2003 461 465
19. M.J. Barry, and A.J. Mulley Jr. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important? J Natl Cancer Inst 101 2009 362 363
20. K.A. Roehl, S. Loeb, J.A. Antenor, N. Corbin, and W.J. Catalona Characteristics of patients with familial versus sporadic prostate cancer J Urol 176 2006 2438 2442 discussion 2442
21. S. Roemeling, M.J. Roobol, S.H. de Vries, C. Gosselaar, T.H. van der Kwast, and F.H. Schroder Prevalence, treatment modalities and prognosis of familial prostate cancer in a screened population J Urol 175 2006 1332 1336
22. K. Hemminki, J. Ji, A. Forsti, J. Sundquist, and P. Lenner Concordance of survival in family members with prostate cancer J Clin Oncol 26 2008 1705 1709
23. G. Aus, D. Robinson, J. Rosell, G. Sandblom, and E. Varenhorst Survival in prostate carcinoma - outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden Cancer 103 2005 943 951
24. H. Hampel, K. Sweet, J.A. Westman, K. Offit, and C. Eng Referral for cancer genetics consultation: a review and compilation of risk assessment criteria J Med Genet 41 2004 81 91